How does asafoetida work for digestion?

Asafoetida contains bioactive compounds including ferulic acid, farnesiferol, and umbelliprenin that contribute to its digestive effects. The resin acts as an antispasmodic by relaxing smooth muscle tissue in the gastrointestinal tract, which helps relieve cramping and flatulence. Ferulic acid has demonstrated antioxidant and anti-inflammatory properties in laboratory studies. The herb also stimulates digestive enzyme secretion, enhancing overall digestive function. Evidence level: C (preliminary evidence from traditional use and limited modern research).

Does asafoetida interact with blood thinners or anticoagulants?

Yes, asafoetida may interact with anticoagulant and antiplatelet medications. The resin contains compounds that can affect blood clotting, potentially increasing bleeding risk when combined with blood thinners such as warfarin, aspirin, clopidogrel, or other anticoagulants. Individuals taking these medications should avoid therapeutic doses of asafoetida and consult a healthcare provider before use. This contraindication is based on pharmacological evidence and traditional safety guidance. Evidence level: C.

What is the recommended dosage of asafoetida?

The typical adult dosage of asafoetida resin ranges from 0.2 to 1 gram daily. In culinary use, smaller amounts are used as a spice, typically a pinch to 1/4 teaspoon per serving. For therapeutic purposes, the resin is often taken in divided doses with food to reduce gastrointestinal irritation. Dosage recommendations are based on traditional use in Unani and Ayurvedic medicine rather than standardized clinical trials. Evidence level: Traditional.

Is asafoetida safe during pregnancy?

No, asafoetida is not considered safe during pregnancy. The resin contains compounds that can stimulate uterine contractions, particularly at higher therapeutic doses, which may increase the risk of miscarriage or premature labor. Pregnant women should avoid medicinal doses of asafoetida entirely. Small culinary amounts used in cooking are generally considered lower risk, but medical guidance recommends complete avoidance during pregnancy as a precaution. Evidence level: C.

What is asafoetida used for in herbal medicine?

Asafoetida is primarily used as a digestive aid and antispasmodic agent in traditional Unani and Ayurvedic medicine. Common applications include treating flatulence, bloating, irritable bowel syndrome (IBS), and intestinal spasms. Historically, it was also used as a nervine remedy for hysteria and nervous conditions. The resin's strong sulfur-containing compounds give it a distinctive odor but contribute to its carminative and therapeutic properties. Evidence level: C (preliminary evidence supporting traditional uses).

Ferula Assafoetida Herb (Ferula assa-foetida)

Fiche d'information compilée à partir de PubMed

Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.

Compilé à partir de 30 articles PubMed · modèle : gemma4:31b

Résumé

Ferula assa-foetida is an oleo-gum-resin obtained from the roots of the Ferula assa-foetida plant, traditionally used for various medicinal purposes and as a culinary spice [PMID:31629871, PMID:21130854].

Contexte

Asafoetida is an oleo-gum-resin exudate from the roots of Ferula assa-foetida L. and other Ferula species, distributed across central Asia and the Mediterranean area [PMID:31629871, PMID:25657791].

Usages traditionnels

Traditionally used to treat asthma, gastrointestinal disorders, intestinal parasites [PMID:31629871, PMID:21130854], and is considered in Iranian traditional medicine to be sedative, analgesic, carminative, antispasmodic, diuretic, antihelmintic, emmenagogue, and expectorant [PMID:25657791]. It has also been used for hysteria and other nervous disorders [PMID:33456735].

Composés actifs

Main compounds include monoterpenes, sulfide compounds, polyphenols [PMID:37034135], sugars, sesquiterpene coumarins (such as farnesiferol C, conferone, badrakemin, feslol, isosamarcandin, and samarcandin), and polysulfides [PMID:21130854, PMID:28948835, PMID:26134757]. Specific identified metabolites include foetisulfide C, assafoetidnol A, gumosin, and flabellilobin (A/B) [PMID:36738001].

Mécanisme d'action

Evidence suggests activities including antioxidant, anti-inflammatory, and anti-apoptotic effects [PMID:28725631, PMID:33456735]. It may modulate the microbiome-gut-brain axis to alleviate dyspepsia symptoms [PMID:41054174] and exhibit antinociceptive effects in thermal and acetic acid-induced tests [PMID:25657791].

Preuves cliniques

Preuve BFunctional Dyspepsia

A self-emulsifying hydrogel formulation (250 mg/d) significantly improved symptoms of early satiety, bloating, and heartburn [PMID:41054174]

Preuve BPolycystic Ovary Syndrome (PCOS)

Administration of 100 mg twice daily for 3 months significantly decreased the number of ovarian follicles compared to placebo [PMID:37655000]

Preuve DCancer

Organosulfides from the gum showed significant in-vitro inhibition of SKOV3 and A549 cancer cell growth [PMID:33960249]; in-vivo studies in mice showed antitumor effects against 4T1 breast cancer cells [PMID:28690055]

Preuve DDiabetes/Nephropathy

In rat models, 50 mg/kg oral dose reduced glucose, cholesterol, and HbA1c, and decreased serum creatinine and urea [PMID:38910415]; ethanolic extract (150-250 mg/kg) improved serum glucose and insulin levels [PMID:35474229]

Preuve DPain/Inflammation

Demonstrated antinociceptive effects in mice [PMID:25657791] and anti-inflammatory effects against TNF-α-stimulated HUVECs in vitro [PMID:36091666]

Preuve D

Sécurité et effets indésirables

In rodents, acute oral doses up to 5 g/kg and subchronic doses of 250 mg/kg for 28 days showed no significant changes in body weight or hematological parameters, though mild liver thrombosis and glomerular tuft atrophy were noted [PMID:27047139]. Asafoetida oil is considered an irritant to skin and eyes, and a dermal and respiratory sensitiser [PMID:36570350].

Synthèse des preuves

Evidence is primarily based on in-vitro studies and animal models (Level D), with limited clinical evidence from small-scale RCTs (Level B) regarding PCOS and functional dyspepsia.

Sources PubMed

1.PMID: 31629871 (2019) — NMR-based metabolomic study of asafoetida. · Fitoterapia
2.PMID: 37034135 (2023) — Anticancer potential of Ferula assa-foetida and its constituents, a powerful plant for cancer therapy. · World journal of biological chemistry
3.PMID: 36570350 (2022) — Safety and efficacy of a feed additive consisting of an essential oil from the gum resin of Ferula assa-foetida L. (asafoetida oil) for use in dogs and cats (FEFANA asbl). · EFSA journal. European Food Safety Authority
4.PMID: 21130854 (2011) — Traditional uses, phytochemistry and pharmacology of asafoetida (Ferula assa-foetida oleo-gum-resin)-a review. · Journal of ethnopharmacology
5.PMID: 38604334 (2024)

Ferula Assafoetida Herb

Sources et citations